Straight Path Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.22M Hold
6,250
– – 0.5% 27
2026
Q2
$3.02M Hold
6,250
– – 0.71% 21
2026
Q1
$685K Sell
6,250
-500
-7% -$71.2K 0.18% 52
2025
Q4
$1.12M Sell
6,750
-100
-1% -$16.7K 0.3% 32
2025
Q3
$1.34M Hold
6,850
– – 0.36% 35
2025
Q2
$619K Buy
6,850
+100
+1% +$7.9K 0.21% 48
2025
Q1
$403K Buy
+6,750
New +$624K 0.16% 58

Other funds holding ALAB

Straight Path Wealth Management's ALAB Position: Q3 2026 in Review

Straight Path Wealth Management held its Astera Labs (ALAB) position steady in Q3 2026 at 6,250 shares worth $2.22M. The position accounts for 0.5% of the portfolio, ranked #27.

Straight Path Wealth Management first reported a position in ALAB in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.02M in Q2 2026. 199 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Straight Path Wealth Management held 6,250 shares of Astera Labs worth $2.22M as of Q3 2026.
  • Straight Path Wealth Management left its Astera Labs share count unchanged in Q3 2026.
  • Astera Labs made up 0.5% of Straight Path Wealth Management's portfolio in Q3 2026, its #27 holding.
  • Straight Path Wealth Management first reported a position in Astera Labs in Q1 2025 and has held it in 7 quarters since.
  • Straight Path Wealth Management's Astera Labs position peaked at $3.02M in Q2 2026.
  • 199 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Straight Path Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.